More PRNewswire
View Older Stories View Newer Stories-
Announcement of Tender Offers for Any and All of the 2027 Notes and a portion of the 2028 Notes by Nexa Resources S.A.
-
Ballard announces largest order in company history - 1,000 engines to power Solaris buses across Europe
-
Celestial Seasonings® Reinforces Commitment to Sustainability by Eliminating an Estimated 165,000 Pounds of Plastic Waste Annually
-
IXL Learning Acquires Dictionary.com and Thesaurus.com
-
DFC 4000 HybriDynamic Brake Pads: Bridging the Gap - Beyond Better, Approaching Best
-
Columbia Banking System Announces Date of First Quarter 2024 Earnings Release and Conference Call
-
Strategic Shift: Knight Watch Inc. Announces Key Leadership Transitions
-
United Airlines Names Michelle Freyre to Board of Directors
-
GOODYEAR TAKES INNOVATION TO NEW HEIGHTS WITH SKYGRIP™ TIRES FOR BLIMPS
-
BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update
-
Kellanova Sets Date for 2024 First Quarter Results Webcast
-
Paste Media Expands Its Portfolio with Acquisition of The A.V. Club
-
American Liver Foundation Celebrates Donate Life Month with New Patient Resources, Programs and Support
-
Cadent Announces Intent to Acquire Performance Advertising Pioneer AdTheorent
-
NeuroBo Pharmaceuticals Completes Enrollment of Part 1 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
-
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager
-
Air Premia Joins TSA PreCheck® Program, Expediting Security Screening for U.S. Travelers
-
Vallen Distribution Completes Acquisition of Wesco Integrated Supply
-
Alliance Creative Group (ACGX) Releases 2023 Annual Financial and Disclosure Report - PeopleVine's revenue increased by 100% in 2023
-
The Shop Men's Grooming Line Is Now Available Nationwide
-
Next Bridge Hydrocarbons Announces Transactions
-
Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development
-
Sarah Jessica Parker Faces A Dilemma Of Grand Proportion In New Campaign For Solitaire Grand Harvest
-
Scienjoy Subsidiary, Scienjoy Meta Technology L.L.C, Introduces AI Mate & AI Vision: Entering a New Era of Predictive Personal Assistance
-
Lots of Peddling in Kansas City's West Bottoms From Bikes to Shops
-
Haemonetics Corporation Completes Acquisition of Attune Medical
-
Boston Scientific Announces Conference Call Discussing First Quarter 2024 Results
-
Daqo New Energy's Subsidiary Xinjiang Daqo Proposes 2023 Cash Dividend for Approval at Its Annual Shareholders' Meeting
-
Avantor® to Host First Quarter 2024 Earnings Call on Friday, April 26, 2024
-
Silfab Solar Names Trevor Carson as Chief Financial Officer
-
CIBC continues commitment to affordable housing with latest project: Thrive on King
-
New Kentucky Law Will Protect Homebuyers from Predatory Contracts
-
Results of New Study Reveal the Importance of Multiple Financial Education Interventions
-
d'Alba's Vegan Beauty Revolution: White Truffle Spray Serum Takes Global Market by Storm
-
S&P Global to Launch S&P Global Kuwait PMI®, Expanding Survey Coverage in GCC
-
ADP to Announce Third Quarter Fiscal 2024 Financial Results on May 1, 2024
-
FairPlay Partners With Oscilar to Offer AI Fairness Tools to Its Customers
-
TSC Alliance® Announces 23rd Annual Step Forward to Cure TSC®
-
American Egg Board Presents 47th Annual First Lady's Commemorative Egg to Dr. Jill Biden
-
Join Els for Autism® in Celebrating World Autism Month: Creating Opportunities for Inclusion and Acceptance of Individuals with Autism Spectrum Disorder
-
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
-
Jack Henry Publishes Annual Sustainability Report
-
ViaLase Closes $40 million Series C Financing to Advance First Femtosecond Laser for the Treatment of Glaucoma
-
Actinium Announces Iomab-B Phase 3 SIERRA Trial Results Demonstrating Survival Benefit in High-Risk Relapsed or Refractory Acute Myeloid Leukemia Patients with TP53 Mutations Accepted for Oral Present
-
Clearstead Advisors Announces Acquisition of Wilbanks Smith and Thomas
-
Flash News: OKX Wallet Now Integrated with Bebop, an Innovative Trading App and Suite of APIs
-
MagnusCards Accessibility App Widens Reach by Offering Five New Languages
-
Nuvilab Delivers Keynote Speech at Aramark Innova Summit in Chile
-
Peraton Appoints Tom Terjesen as Chief Information Officer
-
Darcy Partners Announces Top Oil & Gas Innovators of 2023

